Sentences with phrase «stage of breast cancer»

Plaintiff herself was diagnosed with an early stage of breast cancer in January 2000.

Our results provide supportive evidence of the important role of dietary exposures during a unique period in a woman's life in the earlier stage of breast carcinogenesis [the early stage of breast cancer development].

Also called pre-cancer, this is the earliest stage of breast cancer.

When the researchers excluded permed samples, focusing on pubic hair instead, they found the same diffuse ring on the scatter patterns from all 23 women with various stages of breast cancer.

Compared with non-Hispanic whites, women of all other racial and ethnic groups were more likely to be diagnosed with more advanced stages of breast cancer, the researchers found.

Not exact matches

Backstage, Parker introduced Yee to Twitter co-founder Jack Dorsey and to Elizabeth Edwards — the wife of Sen. John Edwards — who had Stage 4 breast cancer and was donning a chic wig for the evening.

We spoke with client, Brenda Alkins, about her inspiring journey with Pure Barre and why she made taking class a part of her daily routine, despite being diagnosed with stage three breast cancer.

I was just returning to the workouts when I was diagnosed with stage three breast cancer at the end of October 2015.

Juno also has a few other compounds in early stages of development aimed at treating NHL, pediatric ALL, multiple myeloma, ovarian & breast cancer, AML, lung cancer, and more.

The study discovered that stage 3 and 4 breast cancer women who supplemented their diet with virgin coconut oil during breast cancer treatment improved fatigue, dyspnea, sleep difficulties, and loss of appetite compared to the control group.

Washington (CNN)- Landra Reid, the wife of Senate Majority Leader Harry Reid, has been diagnosed with stage II breast cancer, according to a Senate democratic leadership aide.

As part of her treatment, Lee underwent a double mastectomy for early stage breast cancer.

«From speaking to the women who call our helpline Breast Cancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregBreast Cancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregCancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregbreast cancer can be at any stage of life, let alone during pregcancer can be at any stage of life, let alone during pregnancy.

A number of witnesses were to testify in favor of a marriage equality plank in the platform: Marc Solomon, national campaign director for Freedom to Marry; Allison Herwitt, legislative director for the Human Rights Campaign; Army Chief Warrant Officer Charlie Morgan, a lesbian New Hampshire guardsman with stage - four incurable breast cancer and a plaintiff in Servicemembers Legal Defense Network's lawsuit against the Defense of Marriage Act; Michael Macleod - Ball, the American Civil Liberties Union's chief of staff for the Washington Legislative Office; and Aaron Zellhoefer, a gay delegate to the Democratic National Convention representing the National Stonewall Democrats.

On average, between 2006 - 2010, only 66 % of the breast cancer cases in Erie County were diagnosed at an early stage, so we have a great deal of room for improvement.»

In her opinion, it remains essential to screen aggressively for breast cancer in hopes of catching the disease in an early, treatable stage.

The trial has also included 10 HER -2-negative breast cancer patients, all of them in early stages of the disease.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

While women with early stage breast cancer often are cured of their disease, they live with surgical consequences throughout survivorship.

Professor Arnie Purushotham, Cancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curinCancer Research UK's senior clinical adviser, said: «One of the challenges when treating early stage breast cancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curincancer is trying to minimise the side effects that can have a real impact on a woman's life, without affecting the chances of curing her.

What are the challenges of detecting breast cancer in its early stages?

While one drug, MEK inhibitor, is usually used in advanced - stage melanoma, the other drug, CDK4 / 6 inhibitor, palbociclib, is currently FDA - approved for treatment of Estrogen Receptor - positive breast cancer patients.

Extending national breast cancer screening programs to women over the age of 70 does not result in a decrease in the numbers of cancers detected at advanced stages, according to new research from The Netherlands.

They found that after the extension of the upper age limit, the incidence of early stage breast cancer (stages 0, I and II) increased significantly from 260 cases per 100,000 women in 1995 to up to 382 cases per 100,000 women in 2011.

An analysis of nearly 273,000 patients showed that between 2013 and 2014 there was a 1 % increase in the percentage of breast, lung, and colorectal cancers diagnosed at the earliest, most treatable stage.

Instead, researchers told the European Breast Cancer Conference that their findings suggest that extending screening programs to older women results in a large proportion of women being over-treated, and at risk from the harmful effects of such treatment, because these women were more likely to die from other causes than from any tumors detected in the early stages of growth.

Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric oncology research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast cancer would increase while the incidence of advanced stage cancer would decrease because any cancer would have been detected at an earlier stage.

Key Findings Researchers found a 1 % increase in stage I diagnoses for four of the five cancers detectable by screening: breast (from 47.8 % to 48.9 %) and cervical cancer (47.3 % vs. 48.8 %, although this difference was not statistically significant) in women, and lung (from 16.6 % to 17.7 %) and colorectal cancer (22.8 % vs. 23.7 %) in men and women.

The five types of cancers analyzed in this study have screening methods that allow for detection at an early stage, though in some instances, debate remains over efficacy and appropriate use: mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear and / or HPV test for cervical cancer, spiral computed tomography or CT for lung cancer, and PSA test for prostate cancer.

Therefore, screening could result in over-treatment and consequently in decreased quality of life and ability to function in older breast cancer patients, without lowering the incidence of advanced stage breast cancer or deaths from the disease,» he said.

But the early stage work is promising, he says, because it holds out hope that doctors will soon be able to image breast cancer with several techniques simultaneously, significantly increasing the chances of spotting the disease in its earliest stages.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researcancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researCancer Center researchers.

Among women diagnosed with early - stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast - conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.

The current PALOMA - 3 study demonstrates benefit in a population of women with a later stage of metastatic breast cancer.

The findings provide the highest level of evidence supporting expert - derived clinical practice guidelines which have recommended Oncotype DX in patients with early stage ER - positive breast cancer.

Now a team of researchers from Central South University in China have demonstrated that a technique known as photoacoustic imaging, which is already under investigation for detecting skin or breast cancers and for monitoring therapy, also has the potential to be a new, faster, cheaper and non-invasive method to detect, diagnose and stage cervical cancer with high accuracy.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

Initial results were announced from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, Inc..

Researchers from BUSM and the University of Cyprus compared the markers on the surface of the cancer cells to gene expression profile of breast tumors deposited by researchers in international public databases and found that a molecule named IL13RA2 (IL13R alpha2) was abundant in metastatic or late - stage BLBC.

The study, published in Cancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagCancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagcancer and were employed at the time of their diagnosis.

Since small, early - stage cancers are the most responsive to drug treatments, screening is an important aspect of follow - up care for breast cancer patients, and early detection is critical in tailoring appropriate and effective therapeutic interventions.

Researchers at the Memorial Sloan Kettering Cancer Center found that while FDG PET / CT is valuable for systemic staging of stage III ductal breast cancer, it adds little to the systemic staging oCancer Center found that while FDG PET / CT is valuable for systemic staging of stage III ductal breast cancer, it adds little to the systemic staging ocancer, it adds little to the systemic staging of ILC.

When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer Ccancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer CCancer Center.

«We are evaluating patient and disease factors that affect the value of FDG PET / CT for systemic staging of locally advanced breast cancer,» said study coauthor Molly Parsons.

Breast cancer cells that spread to other parts of the body break off and leave the primary tumour at late stages of disease development, scientists from the Wellcome Trust Sanger Institute and their collaborators have found.

This shows promise for breast cancer patients as diagnosing and treating the breast cancer at early stages means there is a greater chance of preventing cancer cells spreading to other tissues, such as the lungs, brain and bone.

A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves — despite the fact that knowing your genetic status may help catch the disease in its earliest stages.

Dr. Narod, who is also a Tier 1 Canada Research Chair in Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cCancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cancercancer: